GAP vs JAZZ · P/E 9.9, rev $15.09B vs P/E 1988, rev $4.07B
The Gap, Inc. (GAP) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
GAP currently screens at market cap $7.73B and trailing P/E 9.9. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the GAP and JAZZ stock pages for the full models.
Not investment advice.